Inhale Therapeutic Systems, Centeon L.L.C. deal

The companies will develop a pulmonary formulation of alpha-1 proteinase inhibitor to

Read the full 127 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE